We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$54.4B
AUM Growth
+$4.48B
Cap. Flow
+$2.1B
Cap. Flow %
3.86%
Top 10 Hldgs %
19.38%
Holding
3,633
New
237
Increased
1,748
Reduced
1,306
Closed
214

Sector Composition

Rank Sector Weight
1 Technology 9.7%
2 Financials 9.06%
3 Healthcare 7.76%
4 Industrials 6.89%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWX
101
DELISTED
Time Warner Inc
TWX
$105M 0.19%
1,146,662
+30,528
+3% +$2.88M
TFC icon
102
Truist Financial
TFC
$63.4B
$104M 0.19%
2,082,589
+43,982
+2% +$2.12M
CVS icon
103
CVS Health
CVS
$134B
$103M 0.19%
1,419,847
-146,560
-9% -$10.7M
VEA icon
104
Vanguard FTSE Developed Markets ETF
VEA
$230B
$103M 0.19%
2,290,582
+96,481
+4% +$4.26M
GE icon
105
GE Aerospace
GE
$383B
$100M 0.18%
1,201,069
-242,223
-17% -$23.1M
WELL icon
106
Welltower
WELL
$168B
$99.9M 0.18%
1,566,125
-56,605
-3% -$3.8M
EFG icon
107
iShares MSCI EAFE Growth ETF
EFG
$16.7B
$99.6M 0.18%
1,233,671
+66,121
+6% +$5.24M
RTN
108
DELISTED
Raytheon Company
RTN
$97.3M 0.18%
517,845
-3,338
-0.6% -$623K
NVS icon
109
Novartis
NVS
$292B
$95.8M 0.18%
1,273,632
+58,561
+5% +$4.42M
SO icon
110
Southern Company
SO
$107B
$95.2M 0.18%
1,980,426
-29,217
-1% -$1.49M
MDT icon
111
Medtronic
MDT
$111B
$91.3M 0.17%
1,130,147
+12,325
+1% +$987K
WY icon
112
Weyerhaeuser
WY
$18.2B
$91.1M 0.17%
2,583,495
+273,913
+12% +$9.69M
GIS icon
113
General Mills
GIS
$19.2B
$90.8M 0.17%
1,530,995
-263,014
-15% -$14.2M
EMR icon
114
Emerson Electric
EMR
$86.7B
$90.5M 0.17%
1,298,443
-2,710
-0.2% -$176K
RTX icon
115
RTX Corp
RTX
$292B
$90.3M 0.17%
1,124,429
+91,226
+9% +$6.93M
NVDA icon
116
NVIDIA
NVDA
$5.01T
$90.1M 0.17%
18,619,080
+380,120
+2% +$1.89M
IRM icon
117
Iron Mountain
IRM
$36.9B
$89.8M 0.17%
2,380,643
-152,969
-6% -$6.07M
MET icon
118
MetLife
MET
$62B
$89.8M 0.16%
1,775,321
+54,243
+3% +$2.86M
IBM icon
119
IBM
IBM
$213B
$88.9M 0.16%
606,355
+95,540
+19% +$13.9M
EPD icon
120
Enterprise Products Partners
EPD
$81.9B
$88.8M 0.16%
3,351,350
-129,254
-4% -$3.27M
CELG
121
DELISTED
Celgene Corp
CELG
$88.5M 0.16%
847,730
-283,741
-25% -$32M
AGN
122
DELISTED
Allergan plc
AGN
$87.1M 0.16%
532,596
-50,816
-9% -$9.12M
FVD icon
123
First Trust Value Line Dividend Fund
FVD
$8.33B
$86M 0.16%
2,787,842
+150,856
+6% +$4.6M
BND icon
124
Vanguard Total Bond Market
BND
$157B
$85.5M 0.16%
1,047,717
+74,246
+8% +$6.06M
ADSK icon
125
Autodesk
ADSK
$49.6B
$85.2M 0.16%
812,510
-45,052
-5% -$5.25M

Similar funds

Raymond James & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Raymond James & Associates held 3,633 positions worth $54.4B, up 9% from $49.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Raymond James & Associates deployed $2.1B of net new capital in Q4 2017, opening 237 new positions and adding to 1,748 existing holdings. Its largest new stake was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $124M trimmed.

  • Raymond James & Associates's largest Q4 2017 buy was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.
  • Raymond James & Associates added most to iShares MSCI USA Min Vol Factor ETF in Q4 2017, an estimated $516M increase.
  • Raymond James & Associates's biggest Q4 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $124M.
  • Raymond James & Associates fully exited ABM Industries in Q4 2017, selling an estimated $3.17M.
  • Raymond James & Associates's ten largest holdings make up 19% of its $54.4B portfolio in Q4 2017.
  • Raymond James & Associates opened 237 new positions and closed 214 in Q4 2017.
  • Raymond James & Associates's portfolio value rose 9% quarter-over-quarter to $54.4B.

Based on Raymond James & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.